Berta Caballol

5PUBLICATIONS
34CO-AUTHORS
Immunogenetics (incl. genetic immunology)Medical devicesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Surface properties of condensed matter
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 22, 2026
Outcomes and Reclassification Patterns in Inflammatory Bowel Disease Unclassified: A Multicenter Study Matched With Ulcerative Colitis From Spanish ENEIDA Registry.

|Jul 18, 2025
Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes.

Berta Caballol, Ingrid Ordás, Carolina Saavedra

|May 05, 2025
Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patients.

Elisa Melón-Ardanaz, Marisol Veny, Ana M Corraliza

|Aug 22, 2024
Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry.

Marisa Iborra, Berta Caballol, Alejandro Garrido

|Sep 23, 2022
Fecal Calprotectin for Small Bowel Crohn's Disease: Is It a Cutoff Issue?

Cristina Romero-Mascarell, Gloria Fernández-Esparrach, Cristina Rodríguez-De Miguel

Pageof 1

Frequent Collaborators

3 joint publications

Agnès Fernández-Clotet

2 joint publications

Julian Panés

1 joint publications

M González-Vivó

1 joint publications

I Pérez-Martínez